Development of an orally available inhibitor of CLK1 for skipping a mutated dystrophin exon in Duchenne muscular dystrophy

Duchenne muscular dystrophy (DMD) is a fatal progressive muscle-wasting disease. Various attempts are underway to convert severe DMD to a milder phenotype by modulating the splicing of the dystrophin gene and restoring its expression. In our previous study, we reported TG003, an inhibitor of CDC2-li...

Descripción completa

Detalles Bibliográficos
Autores principales: Sako, Yukiya, Ninomiya, Kensuke, Okuno, Yukiko, Toyomoto, Masayasu, Nishida, Atsushi, Koike, Yuka, Ohe, Kenji, Kii, Isao, Yoshida, Suguru, Hashimoto, Naohiro, Hosoya, Takamitsu, Matsuo, Masafumi, Hagiwara, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448077/
https://www.ncbi.nlm.nih.gov/pubmed/28555643
http://dx.doi.org/10.1038/srep46126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448077/
https://www.ncbi.nlm.nih.gov/pubmed/28555643
http://dx.doi.org/10.1038/srep46126

Ejemplares similares